Literature DB >> 10336098

Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV.

N Kawakami1, N Takatsuka, S Inaba, H Shimizu.   

Abstract

A 10-item questionnaire (the Tobacco Dependence Screener; TDS) for screening of tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV was newly developed. The reliability and validity were assessed in three samples of smokers in Japan. A total of 58 male smokers completed the TDS and the Fagerstrom Tolerance Questionnaire (FTQ), and they were interviewed using the World Health Organization's Composite International Diagnostic Interview (Sample 1). A total of 118 male and 36 female smoking outpatients completed the TDS and the FTQ and provided a breath sample for carbon monoxide measurement (Sample 2). A total of 194 male smokers joined a health education program using a health risk appraisal (HRA) and reported their smoking status and completed the TDS 6 months after receiving the HRA results (Sample 3). The Cronbach's alpha coefficients for the TDS ranged from .74 to .81 among the samples, whereas those for the FTQ ranged from .41 to .64. Receiver operator characteristic analyses indicated that the TDS had a better screening performance for ICD-10, DSM-III-R, and DSM-IV diagnoses than did the FFQ. The TDS score significantly and positively correlated with the severity of the diagnoses, the carbon monoxide levels, number of cigarettes smoked per day, and years of smoking. The TDS score was significantly lower in those who quit smoking than in those who did not quit smoking after the HRA. It is suggested that the TDS is a reliable and useful screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV.

Entities:  

Mesh:

Year:  1999        PMID: 10336098     DOI: 10.1016/s0306-4603(98)00127-0

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  48 in total

1.  Psychosocial versus nicotine-only self-report measures for predicting follow-up smoking status.

Authors:  W J McCarthy; Y Zhou; Y I Hser
Journal:  J Behav Med       Date:  2001-02

2.  Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt.

Authors:  Megan E Piper; Susan Kenford; Michael C Fiore; Timothy B Baker
Journal:  Ann Behav Med       Date:  2012-04

3.  Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.

Authors:  James Robert Brašić; Nicola Cascella; Anil Kumar; Yun Zhou; John Hilton; Vanessa Raymont; Andrew Crabb; Maria Rita Guevara; Andrew G Horti; Dean Foster Wong
Journal:  Synapse       Date:  2011-12-29       Impact factor: 2.562

4.  Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence.

Authors:  Timothy B Baker; Megan E Piper; Tanya R Schlam; Jessica W Cook; Stevens S Smith; Wei-Yin Loh; Daniel Bolt
Journal:  J Abnorm Psychol       Date:  2012-05-28

5.  Efficacy of bupropion alone and in combination with nicotine gum.

Authors:  Megan E Piper; E Belle Federman; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Timothy B Baker
Journal:  Nicotine Tob Res       Date:  2007-09       Impact factor: 4.244

6.  Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers.

Authors:  James Robert Brasić; Yun Zhou; John L Musachio; John Hilton; Hong Fan; Andrew Crabb; Christopher J Endres; Melvin J Reinhardt; Ahmet S Dogan; Mohab Alexander; Olivier Rousset; Marika A Maris; Jeffrey Galecki; Ayon Nandi; Dean F Wong
Journal:  Synapse       Date:  2009-04       Impact factor: 2.562

7.  The relationship between anxiety, smoking, and gambling in electronic gaming machine players.

Authors:  Simone Rodda; Stephen L Brown; James G Phillips
Journal:  J Gambl Stud       Date:  2004

8.  A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.

Authors:  Megan E Piper; Stevens S Smith; Tanya R Schlam; Michael C Fiore; Douglas E Jorenby; David Fraser; Timothy B Baker
Journal:  Arch Gen Psychiatry       Date:  2009-11

9.  Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM).

Authors:  Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Caryn Lerman; Neal Benowitz; Michael C Fiore; Timothy B Baker
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

Review 10.  Diagnostic Methods for Detection of Cotinine Level in Tobacco Users: A Review.

Authors:  Mitali Raja; Aarti Garg; Pramod Yadav; Kunal Jha; Sahil Handa
Journal:  J Clin Diagn Res       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.